Director at The Second Affiliated Hospital of Nanchang University | China
Huaijun Tu, M.D., is a distinguished Chief Physician, Master’s Supervisor, and Director of the Department of Geriatrics at The Second Affiliated Hospital of Nanchang University. He also serves as Associate Director of the Department of General Practice and has been a visiting scholar at the Movement Disorders Centre of Toronto Western Hospital, University of Toronto. With extensive expertise in geriatric neurology, particularly Parkinson’s disease, cerebrovascular disorders, and movement disorders, he has made significant contributions through clinical practice, research, and academic leadership. His career reflects a remarkable blend of medical excellence, research innovation, and dedication to improving the health and quality of life of elderly patients.
Professional Profile
Scopus Profile
Education
Dr. Tu’s academic journey demonstrates a consistent pursuit of excellence in clinical medicine and neurology. He earned his Bachelor’s degree in Clinical Medicine from Jiangxi Medical College, followed by a Master’s degree in Internal Medicine at Nanchang University School of Medicine. He later completed his Ph.D. in Internal Medicine at the same institution, advancing his expertise in neurology and geriatric care. His overseas academic exposure included an extended study and research period at the University of Toronto, where he specialized in movement disorders. This international experience strengthened his ability to integrate global perspectives into local healthcare systems, particularly in the management of complex neurological diseases.
Experience
Dr. Tu has served in progressively senior roles throughout his medical career, spanning from resident physician to chief physician. His clinical expertise matured through appointments at major hospitals, including long service at The Second Affiliated Hospital of Nanchang University. In his current capacity as Director of the Department of Geriatrics, he leads both clinical services and academic training while shaping strategies for the management of aging-related neurological disorders. Additionally, his tenure as Associate Director of the Department of General Practice reflects his dedication to comprehensive patient care. His leadership also extends to professional organizations, where he actively contributes to committees in geriatrics, gerontology, neuroimmunology, nutrition, and movement disorders. These roles underscore his national and regional influence in shaping healthcare policy and practice for aging populations.
Research Focus
Dr. Tu’s research interests are diverse yet deeply interconnected, focusing on neurological diseases that impact the elderly. His primary investigations revolve around the diagnosis and treatment of Parkinson’s disease, including clinical trials evaluating drug efficacy and exploring the role of gut microbiota in disease progression. He has also directed studies on integrating live bacterial preparations with conventional treatments to alleviate Parkinson’s-related constipation and improve quality of life. Beyond Parkinson’s, his research encompasses cerebrovascular diseases, sarcopenia, frailty, and the clinical mechanisms of age-related disorders. His ability to combine clinical practice with scientific inquiry positions him as a leader in translational research for geriatric neurology.
Awards and Honors
Dr. Tu has received notable recognition for his contributions to medical science and healthcare innovation. His work earned the prestigious Third Prize for Military Scientific and Technological Progress awarded by the General Logistics Department. Additionally, he received the Second Prize for Scientific and Technological Achievements from Jiangxi Universities, further highlighting his impact at both national and regional levels. His numerous leadership appointments within professional societies, including the China Association of Gerontology and Geriatrics and the Chinese Geriatrics Society, stand as additional recognition of his expertise and influence in advancing geriatric medicine.
Publication Top Notes
Title: Cervical vagus nerve as a checkpoint to block the gut-brain transmission of α-Synuclein for early Parkinson’s disease
Journal: Chemical Engineering Journal
Summary: This study highlights the cervical vagus nerve as a regulatory checkpoint, potentially preventing pathological α-synuclein transmission from gut to brain, offering new therapeutic strategies for early Parkinson’s disease.
Title: Lactobacillus acidophilus JYLA-126 Ameliorates Obesity-Associated Metabolic Disorders by Positively Regulating the AMPK Signaling Pathway Through the Gut-Liver Axis
Journal: Probiotics and Antimicrobial Proteins
Summary: Research demonstrates Lactobacillus acidophilus JYLA-126 improves obesity-related metabolic dysfunctions by modulating AMPK signaling via the gut-liver axis, highlighting its therapeutic potential for managing obesity and metabolic disorders.
Title: Association of CVAI, LAP and SMI with risk of haematological toxicity after immunochemotherapy in patients with DLBCL: a retrospective study
Journal: Therapeutic Advances in Hematology
Summary: This retrospective study evaluates associations of CVAI, LAP, and SMI with hematological toxicity risks in DLBCL patients receiving immunochemotherapy, identifying predictive indicators for personalized treatment strategies.
Conclusion
Dr. Huaijun Tu’s career epitomizes the integration of clinical excellence, innovative research, and academic leadership in geriatric neurology. His educational background, clinical experience, and international training have equipped him to lead groundbreaking projects addressing Parkinson’s disease, cerebrovascular disorders, and the challenges of aging. His awards underscore his lasting contributions to medical science, while his publications and supervised graduate students demonstrate his commitment to advancing knowledge and mentoring the next generation of physicians. Through his leadership in professional societies and his active role in clinical research, Dr. Tu has significantly shaped the field of geriatric medicine in China and beyond. His work continues to advance the diagnosis, treatment, and quality of life for elderly patients, making him an outstanding candidate for recognition in this award nomination.